Journal of Medical Economics, Volume 15, Issue sup2 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 15, Issue sup2 (2012)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Volume 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Original Article

Article
Willingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results
J. Jendle, O. Torffvit, M. Ridderstråle, Å. Ericsson, B. Nilsen & M. Bøgelund
Pages: 1-5
Published online: 01 Aug 2012
AbstractforWillingness to pay for diabetes drug therapy in type 2 diabetes patients: based on LEAD clinical programme results | Full Text | References | PDF (82.1 KB)
  • 1114 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access
Article
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US
Yevgeniy Samyshkin, Anne-Laure Guillermin, Jennie H. Best, Steven C. Brunell & Adam Lloyd
Pages: 6-13
Published online: 16 Jul 2012
AbstractforLong-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US | Full Text | References | PDF (96.9 KB)
  • 1379 Views
  • 29 CrossRef citations
  • 0Altmetric
Free Access
Article
Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany
Martin Pfohl, Peter K. Schädlich, Franz-Werner Dippel & Katharina C. Koltermann
Pages: 14-27
Published online: 03 Aug 2012
AbstractforHealth economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany | Full Text | References | PDF (546.5 KB)
  • 877 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis
Won Chan Lee, Yevgeniy Samyshkin, Jakob Langer & James L. Palmer
Pages: 28-37
Published online: 13 Aug 2012
AbstractforLong-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis | Full Text | References | PDF (267.1 KB)
  • 2577 Views
  • 15 CrossRef citations
  • 0Altmetric
Free Access

Explore articles